New England Biolabs produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2021. Read More.
Open Access Percentage
76%
Total
Publications
1K
Total Open
Publications
792
Total
Citations
46K
Open Access
Percentage
76%
Total
Publications
1K
Total Open
Publications
792
Total
Citations
46K
Breakdown
Publisher Open
9%
Both
52%
Other Platform Open
15%
Closed
24%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 53%
340
Hybrid 29%
184
No Guarantees 18%
114
Other Platform Open
Domain 90%
631
Institution 24%
169
Public 22%
153
Preprint 10%
72
Other Internet 8%
56
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 628 |
Europe PMC | Domain | 550 |
Semantic Scholar | Public | 146 |
bioRxiv | Preprint | 58 |
DOI | Other Internet | 30 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 22 |
University of Sussex - Sussex Research Online | Institution | 19 |
Figshare | Public | 15 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 13 |
CiteSeer X | Other Internet | 12 |